These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24292413)

  • 1. Novel long-acting prostacyclin agonist (ONO-1301) with an angiogenic effect: promoting synthesis of hepatocyte growth factor and increasing cyclic AMP concentration via IP-receptor signaling.
    Uchida T; Hazekawa M; Yoshida M; Matsumoto K; Sakai Y
    J Pharmacol Sci; 2013; 123(4):392-401. PubMed ID: 24292413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic small molecule, ONO-1301, enhances endogenous growth factor expression and augments angiogenesis in the ischaemic heart.
    Nakamura K; Sata M; Iwata H; Sakai Y; Hirata Y; Kugiyama K; Nagai R
    Clin Sci (Lond); 2007 Jun; 112(12):607-16. PubMed ID: 17263691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model.
    Hazekawa M; Morihata K; Yoshida M; Sakai Y; Uchida T
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1435-42. PubMed ID: 23937583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of acute hepatic injury by a synthetic prostacyclin agonist through hepatocyte growth factor expression.
    Xu Q; Nakayama M; Suzuki Y; Sakai K; Nakamura T; Sakai Y; Matsumoto K
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(4):G420-9. PubMed ID: 22159278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
    Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice.
    Murakami S; Nagaya N; Itoh T; Kataoka M; Iwase T; Horio T; Miyahara Y; Sakai Y; Kangawa K; Kimura H
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L59-65. PubMed ID: 16155090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension.
    Nakamura A; Nagaya N; Obata H; Sakai K; Sakai Y; Yoshikawa M; Hamada K; Matsumoto K; Kimura H
    Circ J; 2013; 77(8):2127-33. PubMed ID: 23676973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
    J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury.
    Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M
    Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sustained prostacyclin analog, ONO-1301, attenuates pancreatic fibrosis in experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
    Niina Y; Ito T; Oono T; Nakamura T; Fujimori N; Igarashi H; Sakai Y; Takayanagi R
    Pancreatology; 2014; 14(3):201-10. PubMed ID: 24854616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice.
    Hayashi M; Koya T; Kawakami H; Sakagami T; Hasegawa T; Kagamu H; Takada T; Sakai Y; Suzuki E; Gelfand EW; Gejyo F
    Clin Exp Allergy; 2010 Feb; 40(2):317-26. PubMed ID: 20015276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MaxiK channel-mediated relaxation of guinea-pig aorta following stimulation of IP receptor with beraprost via cyclic AMP-dependent and -independent mechanisms.
    Yamaki F; Kaga M; Horinouchi T; Tanaka H; Koike K; Shigenobu K; Toro L; Tanaka Y
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):538-50. PubMed ID: 11770009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.
    Camussi G; Montrucchio G; Lupia E; Soldi R; Comoglio PM; Bussolino F
    J Immunol; 1997 Feb; 158(3):1302-9. PubMed ID: 9013973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
    Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
    Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension.
    Kataoka M; Nagaya N; Satoh T; Itoh T; Murakami S; Iwase T; Miyahara Y; Kyotani S; Sakai Y; Kangawa K; Ogawa S
    Am J Respir Crit Care Med; 2005 Dec; 172(12):1575-80. PubMed ID: 16192456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.
    O'Meara SJ; Kinsella BT
    Br J Pharmacol; 2004 Sep; 143(2):292-302. PubMed ID: 15326037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia.
    Umeda S; Miyagawa S; Fukushima S; Oda N; Saito A; Sakai Y; Sawa Y; Okuyama H
    PLoS One; 2016; 11(8):e0161334. PubMed ID: 27529478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin signaling boosts NADPH oxidase 4 in the endothelium promoting cytoprotection and angiogenesis.
    Peshavariya HM; Liu GS; Chang CW; Jiang F; Chan EC; Dusting GJ
    Antioxid Redox Signal; 2014 Jun; 20(17):2710-25. PubMed ID: 24450852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin I2 analogs on macrophage inflammatory protein 1α in human monocytes via I prostanoid receptor and cyclic adenosine monophosphate.
    Tsai MK; Hsieh CC; Kuo HF; Yang SN; Kuo CH; Huang MY; Tsai YM; Lee MS; Hung CH
    J Investig Med; 2014 Feb; 62(2):332-9. PubMed ID: 24402297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.